PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-Sep-2024 Healthcare Data Analytics: Driving Innovation and Efficiency for Business Leaders Mastech InfoTrellis
10-Sep-2024 Enalare Therapeutics Receives Additional Funding From BARDA to Further Advance the Development of Agnostic Respiratory Stimulant (ENA-001) Newswire
10-Sep-2024 Enalare Therapeutics Receives Additional Funding From BARDA to Further Advance the Development of Agnostic Respiratory Stimulant (ENA-001) AccessWire
10-Sep-2024 Altius Bioventures Launches The CGT Industry Atlas, Mapping out the Cell and Gene Therapy Technology Innovation Landscape AccessWire
10-Sep-2024 Carolina Marquez, DPM, Joins Modern Foot & Ankle as New Podiatric Surgeon AccessWire
10-Sep-2024 Book a meeting with Gaelic Laboratories at CPHI Milan! Gaelic Laboratories
10-Sep-2024 Brightflow SAS Raises €16.5M in Series A Financing Round Andrew Lloyd Associates
10-Sep-2024 CD Formulation Launches Special Back to School Promotion for 2024 - Up to 10% Off CD Formulation
10-Sep-2024 Medical Laser Market Set to Reach USD 16.5 Billion by 2032 | Global Insights and Forecasts to 2032 Ameco Research
10-Sep-2024 Pharmaceutical Contract Manufacturing Market Predicted to Register a Revenue of USD 279.3 Billion by & grow at 6.8% CAGR from 2023-2032 Acumen Research and Consulting
09-Sep-2024 BioNxt Receives Positive International Examination Report From the European Patent Office for Broad Patent Application for Sublingual Delivery of Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases AccessWire
09-Sep-2024 Abivax presents first-half 2024 financial results ABIVAX
09-Sep-2024 Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 AccessWire
09-Sep-2024 CELLTech(TM) DBS: Your Brain’s Healing Power Under Your Control AccessWire
09-Sep-2024 iCardio.ai and SARC MedIQ PACS Partner to Revolutionize Ultrasound Interpretation With AI Tools AccessWire
09-Sep-2024 Pierre Fabre Laboratories receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation Pierre Fabre Laboratories
09-Sep-2024 Deafblind UK is proud to announce its highly anticipated 2024 conference, ‘Standing Out and Fitting In’, set to take place online on the 3 October 2024. Deafblind UK
09-Sep-2024 AstraZeneca announces the completion of the clinical programme to support the transition of Breztri to next-generation propellant with near-zero Global Warming Potential AstraZeneca
09-Sep-2024 The OTL Group toasts 40 years of success OTL Group
09-Sep-2024 TILT Biotherapeutics Presents Clinical Data on TILT-123 After Fully Intravenous Delivery Regimen at ESMO 2024 TILT Biotherapeutics